Fujifilm (OTCMKTS:FUJIY) Shares Gap Down - Time to Sell?

Key Points

• Fujifilm's shares experienced a gap down before the market opened on Monday, starting at $11.35 after previously closing at $11.81.
• The stock was dropped from a "buy" to a "hold" rating by Wall Street Zen as of May 23rd.
• The company's recent earnings report revealed an EPS of $0.15, meeting analyst expectations, with total revenue of $5.08 billion for the quarter.

Shares of Fujifilm Holdings Corp. (OTCMKTS:FUJIY - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $11.81, but opened at $11.35. Fujifilm shares last traded at $11.81, with a volume of 1,672 shares traded.

Analyst Ratings Changes

Separately, Wall Street Zen cut shares of Fujifilm from a "buy" rating to a "hold" rating in a report on Friday, May 23rd.

Fujifilm Price Performance

The company has a debt-to-equity ratio of 0.14, a current ratio of 1.40 and a quick ratio of 0.92. The stock has a market cap of $29.88 billion, a price-to-earnings ratio of 10.82, a price-to-earnings-growth ratio of 3.65 and a beta of 0.67. The business's 50-day simple moving average is $10.68 and its two-hundred day simple moving average is $10.44.

Fujifilm (OTCMKTS:FUJIY - Get Free Report) last issued its earnings results on Wednesday, August 6th. The technology company reported $0.15 earnings per share for the quarter, meeting analysts' consensus estimates of $0.15. Fujifilm had a net margin of 7.93% and a return on equity of 7.73%. The firm had revenue of $5.08 billion for the quarter, compared to analyst estimates of $760.41 billion. Research analysts expect that Fujifilm Holdings Corp. will post 0.66 earnings per share for the current year.

Fujifilm Company Profile

FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.